ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
1. 8ÔÂ29ÈÕ£¬¼ÎÒëÉúÎïÒ½Ò©£¨º¼ÖÝ£©ÓÐÏÞ¹«Ë¾Ðû²¼£¬Æä×ÔÖ÷Ñз¢µÄºôÎüµÀºÏ°û²¡¶¾£¨RSV£©mRNAÒßÃ磨NT-INF-001£© Õýʽ»ñµÃ¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾ÖÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©Åú׼ǩ·¢µÄ¡¶Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡·¡£
2. 9ÔÂ1ÈÕ£¬Ê¯ËÄÒ©¼¯ÍÅÐû²¼Í¨¸æ³Æ£¬ÆäÎÚÀµØ¶û»ºÊͽºÄÒ¼°ÑÎËáÄῨµØÆ½ÂÈ»¯ÄÆ×¢ÉäÒºÒÑÈ¡µÃÖйú¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾ÖµÄÒ©Æ·Éú²ú×¢²áÅú¼þ¡£ÕâÁ½¿î»¯Ñ§Ò©Æ·µÚ3Àà»ñÅú£¬ÊÓͬͨ¹ýÒ»ÖÂÐÔÆÀ¼Û£¬ÇÒ¾ùΪº£ÄÚÆóÒµÖÐÊ×¼Ò»ñÅúµÄ²úÆ·¡£
3. 8ÔÂ29ÈÕ£¬ÈÕ±¾ÎÀ²Ä¹«Ë¾ºÍÃÀ¹ú²³½¡¹«Ë¾Ðû²¼£¬ÃÀ¹úFDA£¨ÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£©ÒÑÅú׼ÿÖÜÒ»´ÎµÄÂØ¿¨Ä¹Æ¤ÏÂ×Ô¶¯×¢É䣨SC-AI£©ÖÜά³Ö¼ÁÁ¿ÉÏÊУ¬ÓÃÓÚÖÎÁÆÔçÆÚ°¢¶û´Äº£Ä¬²¡£¨AD£©¡£
4. 8ÔÂ28ÈÕ£¬¿µÕÜÒ©ÒµÆìϵÂþҽҩÁ¬Í¬ÆäÁ¥Êô¹«Ë¾ÓÚ8ÔÂ28ÈÕÊÕµ½Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡£NMPAÔ޳ɿªÕ¹povorcitinib£¨Öƶ©ÖÐÎÄͨÓÃÃû£ºÁ×Ëá²´ÎÖÎôÌæÄáÆ¬£©ÓÃÓڷǽڶÎÐͰ×ñ°·çºÍÖÐÖØ¶È»¯Å§ÐÔº¹ÏÙÑ×£¨HS£©µÄÁÙ´²ÊÔÑé¡£
1. 8ÔÂ31ÈÕ£¬Å·ÁÖÉúÎïͨ¸æ£¬¹«Ë¾ÄâÒÔ×Ô³ï×ʽðÊÕ¹º³É¶¼ÉúÎï³ÇÒ»ºÅ¹ÉȨͶ×Ê»ù½ðºÏ×ÊÆóÒµ£¨ÓÐÏÞºÏ×Ê£©¡¢³É¶¼ÉúÎï³Çݼ´´¹ÉȨͶ×Ê»ù½ðºÏ×ÊÆóÒµ£¨ÓÐÏÞºÏ×Ê£©ºÏ¼Æ³ÖÓеĹ«Ë¾¿Ø¹É×Ó¹«Ë¾³É¶¼ÐÂŵÃ÷ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾15%µÄ¹ÉȨ¡£
1. 8ÔÂ29ÈÕ£¬Ç廪´óѧÃâÒßѧÑо¿ËùÅíÃôÍŶÓÔÚ Nature ×Ó¿¯ Nature Communications ÉϽÒÏþÁËÌâΪ£ºGD2TIF cells as a platform for single-dose and long-term delivery of biologics µÄÑо¿ÂÛÎÄ¡£¸ÃÑо¿¿ª·¢Á˳¤ÊÙÃü CAR-T ϸ°û×÷ΪһÖÖÐÂÐÍÒ©ÎïÌåÄÚµÝËÍÆ½Ì¨£¬¸Ã³¤ÊÙÃü CAR-T ϸ°ûÔÚ¶¯ÎïÄ£×ÓÖÐʵÏÖÁË·ÊÅÖºÍÌÇÄò²¡ÖÎÁÆÒ©Îï GLP-1 µÄºã¾ÃÎȹ̵ÝËÍ£¬Ö»Ðèµ¥´ÎÊäÈë¼´¿Éά³Ö·ÊÅÖºÍÌÇÄò²¡µÄºã¾Ã»º½â£¬ÎªÐèÒªÖÕÉíÖÎÁƵÄÂýÐÔ¼²²¡ÌṩÁËÖÎÓúµÄDZÔÚ¿ÉÄÜÐÔ¡£
[1]Zhang, G., Yin, N. & Peng, M. GD2TIF cells as a platform for single-dose and long-term delivery of biologics. Nat Commun 16, 8088 (2025).